SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Healthcare Global Enterprises Ltd

BSE: 539787 NSE: HCG ISIN: INE075I01017
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Healthcare Global Enterprises Ltd belong to?
Healthcare Global Enterprises Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Healthcare Global Enterprises Ltd a good quality company?
Healthcare Global Enterprises Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is Healthcare Global Enterprises Ltd undervalued or overvalued?
Healthcare Global Enterprises Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Healthcare Global Enterprises Ltd a good buy now?
Healthcare Global Enterprises Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd revenue growth is 9% for FY-2025 , which is below its 5 year CAGR of 13.2% , indicating slower growth.
Q.2 Gross Profit margin of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Gross profit margin which is the profit after deduction of direct costs, is 13% for FY-2025 , which is below its 5 year median of 13.7% , indicating decreasing margins.
Q.3 Operating Profit Margin of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 16.56% for FY-2025 , which is below its 5 year median of 16.93% indicating decreasing margins.
Q.4 Net Profit Margin of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Net Profit Margin is 0.28% for FY-2025 , is below with its 5 year median of 2.8%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 13 13.7
Operating Profit Margin 16.56 16.93
Net Profit Margin 0.28 2.8
Q.5 Return on Asset of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Return on Asset is 0.15%, which is below its 5 year historical median of 1.65%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Return on equity is 0.3% for FY-2025 , which is below its historical median of 2.86%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Return on capital employed is 6.03% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 13.5%, indicating value preservation.
Q.8 Cash conversion cycle of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Cash conversion cycle is 21 days, below its historical median of 26 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.53 0.53
ROE 0.3 2.86
ROCE 6.03 7.25
Cash Conversion Cycle 21 days 26 days
Q.9 Debt to Equity ratio of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Debt-to-Equity ratio is 0.56 , which is above with the industry average of 0.22 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd Debt to cash flow from operations is 4.46 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Healthcare Global Enterprises Ltd?
Promoters hold 63.77% of the Healthcare Global Enterprises Ltd, with 5.52% of their stake pledged, indicating low pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Healthcare Global Enterprises Ltd vs industry peers?
Healthcare Global Enterprises Ltd revenue CAGR is 13.15% , compared to the industry median CAGR of 1.49% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 1,276.5 144
Gross Profit 166 8.2
Operating Profit 211 8.4
Net Profit 4 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.53 0.73
ROE 0.3 13.88
ROCE 6.03 17.77
Cash Conversion Cycle (days) 20.71 2

Valuation & price assessment

Q.1 Stock return of Healthcare Global Enterprises Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 11.6% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 11.6% 27.8% 29% -4%
Q.3 Valuation ratios of Healthcare Global Enterprises Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 364.76 0.00 79.71
Price to Book 5.26 0.00 3.54
Price to Sales 6.32 2.47 4.37
EV to EBITDA 35.68 19.94 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Vijaya Diagnostic
8. Metropolis Health.
9. Park Medi World
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×